skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Long-term efficacy and safety of anastrozole for adjuvant treatment of early breast cancer in postmenopausal women

Review

(2403) Views  (769) Full article downloads

Authors: Sharath Gangadhara, Gianfilippo Bertelli

Published Date April 2009 Volume 2009:5 Pages 291 - 300
DOI: http://dx.doi.org/10.2147/TCRM.S3856

Sharath Gangadhara, Gianfilippo Bertelli

South West Wales Cancer Institute, Singleton Hospital, Swansea, UK

Abstract: For more than 20 years, tamoxifen has been the gold standard for the adjuvant treatment of postmenopausal women with hormone-responsive early breast cancer. However, recent randomized trials have shown efficacy and tolerability benefits with the third-generation aromatase inhibitor anastrozole, resulting in an increased use of this agent in the adjuvant setting. Data on anastrozole’s long-term efficacy and tolerability are therefore of interest in clinical practice and will be reviewed here, especially in the light of the 100-month analysis of the ATAC (Anastrozole, Tamoxifen Alone or in Combination) trial.

Keywords: anastrozole, aromatase inhibitors, breast cancer, adjuvant therapy

 






Readers of this article also read:

Long-term safety of aromatase inhibitors in the treatment of breast cancer
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Exacerbation rate, health status and mortality in COPD – a review of potential interventions
Role of neo-adjuvant hormonal therapy in the treatment of breast cancer: a review of clinical trials
Aromatase inhibitor strategies in metastatic breast cancer
Long-term efficacy and safety of letrozole for the adjuvant treatment of early breast cancer in postmenopausal women: a review
ABO and rhesus blood group distribution in Kurds
FACE: the barefaced facts of AI potency
Improvement of adenoviral vector-mediated gene transfer to airway epithelia by folate-modified anionic liposomes
Primary care for diabetes mellitus: perspective from older patients